Marx Biotechnology
Blood Test for Graft-versus-host Disease
Active
Seed
Startup
Jerusalem
Founded 2011-01
Marx Biotechnology (MBT) develops a blood test to diagnose the early onset of graft-versus-host disease (GVHD) in order to save lives, reduce costs, and improve patient care, allowing doctors to make quick, accurate, and efficient decisions on how best to manage and treat their patients. MBT's blood test will diagnose the early onset of GVHD by monitoring f…
SectorHealth Tech & Life Sciences
StageSeed
Total raised$1.2M
Employees2
Founded2011-01
HQJerusalem
Crunchbasemarx-biotechnology
Patents1
Confidence98
Sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesProviders